These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23112009)

  • 1. Evaluation of a LPS-based glycoconjugate vaccine against bovine Escherichia coli mastitis: Formation of LPS Abs in cows after immunization with E. coli core oligosaccharides conjugated to hemocyanine.
    Brade L; Hensen S; Brade H
    Innate Immun; 2013; 19(4):368-77. PubMed ID: 23112009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5).
    Tyler JW; Spears H; Nelson R
    J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of two commercially available Escherichia coli J5 vaccines against E. coli intramammary challenge.
    Tomita GM; Ray CH; Nickerson SC; Owens WE; Gallo GF
    J Dairy Sci; 2000 Oct; 83(10):2276-81. PubMed ID: 11049068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shielding Effect of Escherichia coli O-Antigen Polysaccharide on J5-Induced Cross-Reactive Antibodies.
    Rainard P; Repérant-Ferter M; Gitton C; Germon P
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33504665
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of route of vaccine administration against experimental intramammary infection caused by Escherichia coli.
    Tomita GM; Nickerson SC; Owens WE; Wren B
    J Dairy Sci; 1998 Aug; 81(8):2159-64. PubMed ID: 9749381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of dairy cows with an Escherichia coli J5 lipopolysaccharide vaccine.
    Tomita GM; Todhunter DA; Hogan JS; Smith KL
    J Dairy Sci; 1995 Oct; 78(10):2178-85. PubMed ID: 8598402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of intramammary immunization with an Escherichia coli J5 bacterin.
    Smith JL; Hogan JS; Smith KL
    J Dairy Sci; 1999 Dec; 82(12):2582-8. PubMed ID: 10629804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opsonic activity of serum and whey from cows immunized with the ferric citrate receptor.
    Wise AJ; Hogan JS; Takemura K; Smith KL
    J Dairy Sci; 2003 Jan; 86(1):146-51. PubMed ID: 12613859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of immunization with ferric citrate receptor FecA from Escherichia coli on induced coliform mastitis.
    Takemura K; Hogan JS; Lin J; Smith KL
    J Dairy Sci; 2002 Apr; 85(4):774-81. PubMed ID: 12018422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Between-cow variation in dermal fibroblast response to lipopolysaccharide reflected in resolution of inflammation during Escherichia coli mastitis.
    Kandasamy S; Green BB; Benjamin AL; Kerr DE
    J Dairy Sci; 2011 Dec; 94(12):5963-75. PubMed ID: 22118085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opsonic activity of bovine serum and mammary secretion after Escherichia coli J5 vaccination.
    Hogan JS; Todhunter DA; Tomita GM; Smith KL; Schoenberger PS
    J Dairy Sci; 1992 Jan; 75(1):72-7. PubMed ID: 1541744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of an Escherichia coli J5 vaccine on mild clinical coliform mastitis.
    Hogan JS; Weiss WP; Smith KL; Todhunter DA; Schoenberger PS; Sordillo LM
    J Dairy Sci; 1995 Feb; 78(2):285-90. PubMed ID: 7745148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine natural antibodies in antibody-dependent bactericidal activity against Escherichia coli and Salmonella Typhimurium and risk of mastitis.
    van Altena SE; Peen MA; van der Linden FH; Parmentier HK; Savelkoul HF; Tijhaar EJ
    Vet Immunol Immunopathol; 2016 Mar; 171():21-7. PubMed ID: 26964714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Field trial to determine efficacy of an Escherichia coli J5 mastitis vaccine.
    Hogan JS; Smith KL; Todhunter DA; Schoenberger PS
    J Dairy Sci; 1992 Jan; 75(1):78-84. PubMed ID: 1541745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of an Escherichia coli J5 bacterin administered to primigravid heifers.
    Hogan JS; Bogacz VL; Aslam M; Smith KL
    J Dairy Sci; 1999 May; 82(5):939-43. PubMed ID: 10342231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of adjuvants on safety and efficacy of an Escherichia coli J5 bacterin.
    Hogan JS; Cannon VB; Smith KL; Rinehart C; Miller S
    J Dairy Sci; 2005 Feb; 88(2):534-42. PubMed ID: 15653518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an alternative dosing regimen of a J-5 mastitis vaccine against intramammary Escherichia coli challenge in nonlactating late-gestation dairy cows.
    Gurjar AA; Klaessig S; Salmon SA; Yancey RJ; Schukken YH
    J Dairy Sci; 2013 Aug; 96(8):5053-63. PubMed ID: 23726420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide pretreatment of the udder protects against experimental Escherichia coli mastitis.
    Petzl W; Günther J; Pfister T; Sauter-Louis C; Goetze L; von Aulock S; Hafner-Marx A; Schuberth HJ; Seyfert HM; Zerbe H
    Innate Immun; 2012 Jun; 18(3):467-77. PubMed ID: 21990573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of cows with novel core glycolipid vaccine induces anti-endotoxin antibodies in bovine colostrum.
    Cross AS; Karreman HJ; Zhang L; Rosenberg Z; Opal SM; Lees A
    Vaccine; 2014 Oct; 32(46):6107-14. PubMed ID: 25242628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different origins.
    Appelmelk BJ; Maaskant JJ; Verweij-van Vught AM; van der Meer NM; Thijs BG; MacLaren DM
    J Gen Microbiol; 1993 Nov; 139(11):2641-7. PubMed ID: 7506295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.